Stage IVB Colon Cancer Active Not Recruiting Phase 2 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0028588 (Stage IVB Colon Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02393755Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal CancerTreatment